| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
38,398 |
25,377 |
$2.51M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,390 |
12,442 |
$243K |
| 99051 |
|
8,934 |
6,098 |
$69K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,207 |
15,181 |
$29K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
4,190 |
3,036 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,457 |
2,860 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
647 |
437 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,595 |
3,684 |
$5K |
| 81003 |
|
7,223 |
4,081 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
362 |
210 |
$641.20 |
| 81025 |
|
3,046 |
1,974 |
$560.55 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,814 |
2,899 |
$496.19 |
| 87430 |
|
32 |
30 |
$294.00 |
| 87807 |
|
280 |
119 |
$265.25 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
301 |
107 |
$258.20 |
| 81002 |
|
134 |
126 |
$229.39 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,052 |
776 |
$87.68 |
| 36415 |
Collection of venous blood by venipuncture |
2,719 |
1,843 |
$78.29 |
| 0011A |
|
253 |
149 |
$77.08 |
| 94760 |
|
1,187 |
644 |
$43.75 |
| 0012A |
|
209 |
131 |
$40.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
540 |
364 |
$25.11 |
| 99000 |
|
11,322 |
7,064 |
$4.25 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
413 |
270 |
$4.20 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,678 |
1,336 |
$0.00 |
| 82962 |
|
210 |
134 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
78 |
34 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
172 |
70 |
$0.00 |
| 91301 |
|
520 |
326 |
$0.00 |
| 99070 |
|
12 |
12 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
17 |
12 |
$0.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
21 |
15 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
44 |
38 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
17 |
16 |
$0.00 |